A First-in-Human Study of CAN04 in Patients With Solid Malignant Tumors
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Ahmad Awada, Professor
Jules Bordet Institute, Brussels, Belgium
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
25 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Landeskrankenhaus Salzburg
Salzburg, Austria
- Medizinische Universität Wien
Vienna, Austria
- Institut Jules Bordet
Brussels, Belgium
- University Hospital Gasthuisberg
Leuven, Belgium
- Chu de Liège
Liège, Belgium
- Aalborg University Hospital
Aalborg, Denmark
- Rigshospitalet, Department of Oncology
Copenhagen, Denmark
- Herlev Og Gentofte Hospital
Herlev, Denmark
- Odense University Hospital
Odense, Denmark
- East Tallinn Central Hospital
Tallinn, Estonia
- Tartu University Hospital
Tartu, Estonia
- Charité Universitätsmedizin Berlin
Berlin, Germany
- Asklepios Klinik Altona
Hamburg, Germany
- Universitätsklinikum Ulm
Ulm, Germany
- Pauls Stradiņš Clinical University Hospital
Riga, Latvia
- Riga East Clinical University Hospital
Riga, Latvia
- the Hospital of Lithuanian University of Health Sciences
Kaunas, Lithuania
- National Cancer Institute
Vilnius, Lithuania
- Netherlands Cancer Institute
Amsterdam, Netherlands
- Erasmus University Medical Center, Department of Medical Oncology
Rotterdam, Netherlands
- Oslo University Hospital, Radiumhospitalet
Oslo, Norway
- Hospital 12 de Octubre
Madrid, Spain
- Hospital Universitario Quirónsalud Madrid
Madrid, Spain
- Hospital Universitario Central de Asturias
Oviedo, Spain
- Karolinska University Hospital
Stockholm, Sweden
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 19 Sept 2017
- Primary completion
- 14 Mar 2024
- Completion
- 14 Mar 2024
- Last update posted
- 22 Aug 2024
- Registered enrollment
- 167
- Registry id
- NCT03267316
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.